T-Cell Response to Staphylococcal Enterotoxin B Is Reduced Among Heart Failure Patients on Ventricular Device Support

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3695-3696

  Kimball, P ^a   Flattery, M ^a   Kasirajan, V ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ARTICLE; CELLULAR IMMUNITY; DEVICE; DISEASE PREDISPOSITION; GRAFT RECIPIENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFECTION COMPLICATION; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; OUTPATIENT; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ENTEROTOXINS; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; LYMPHOCYTE ACTIVATION; SUPERANTIGENS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845436704     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.153     Document Type: Article

References (5)

1. Hupcey B., Polomano R.C., and Boehmer J.P. J Cardiovasc Manag 15 (2004) 9
2. Deng M.C., Erren M., Tjan T.D., et al. Thorac Cardiovasc Surg 2 (1999) 326
3. Itescu S., and John R. Ann Thorac Surg 75 Suppl (2003) S58
4. Rothenburger M., Wilhelm M., Hammel D., et al. Transplant Proc 33 (2001) 1955
5. Woitas R.P., Lechmann M., Jung G., et al. J Immunol 59 (1997) 1012